Aftercare – A Multi-disciplinary Approach

  • Alexandra Geusau
  • Erich Pohanka
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

During the past decades, organ transplantation has become a frequently performed routine procedure offered to patients with end-stage organ failure. Transplant recipients live longer, have a good quality of life, and represent therefore a rapidly growing population. Although the follow-up, and especially the immunosuppressive therapy, are maintained by specialized transplant centers, such patients increasingly appear in private offices or hospitals that lack particular expertise in transplant medicine. Thus, there is need for an educational network for physicians and health care workers and for guidelines how to care best for this cohort of patients.


Transplant Recipient Skin Cancer Renal Transplant Recipient Graft Function Solid Organ Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Grossmann RA. Care of the renal transplant recipient: a field guide for the generalist. Dis Mon 1998; 44:269–82.CrossRefGoogle Scholar
  2. 2.
    Kasiske BL, Vazquez MA, Harmon WE et al., for the American Society of Transplantation. Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 2000; 11(Suppl 15):S1–86.PubMedGoogle Scholar
  3. 3.
    Levitsky J, Cohen SM. The liver transplant recipient: what you need to know for long-term care. J Fam Pract 2006; 55:136–44.PubMedGoogle Scholar
  4. 4.
    Carithers RL Jr. Liver transplantation. American Association for the Study of Liver Diseases. Liver Transplant 2000; 6:122–35.CrossRefGoogle Scholar
  5. 5.
    Oto T, Levvy BJ, Snell GI. Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system. J Heart Lung Transplant 2007; 26:431–36.PubMedCrossRefGoogle Scholar
  6. 6.
    Dipchand A, Cecere R, Delgado D, et al. Canadian Consensus on cardiac transplantation in pediatric and adult congenital heart disease patients 2004: executive summary. Can J Cardiol 2005; 21:1145–147.PubMedGoogle Scholar
  7. 7.
    Mazariegos GV, Sindhi R, Thomson AW, et al. Clinical tolerance following liver transplantation: long term results and future prospects. Transplant Immunol 2007; 17:114–19.CrossRefGoogle Scholar
  8. 8.
    Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338:1741–751.PubMedCrossRefGoogle Scholar
  9. 9.
    Pohanka E. Conversion to everolimus in maintenance patients: current clinical strategies. Nephrol Dial Transplant 2006; 21(Suppl 3):24–9.CrossRefGoogle Scholar
  10. 10.
    Pohanka E, Margreiter R, Sparacino V, Sperschneider H, European Switch to Tacrolimus Study Group. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients. Transplant Proc 2005; 37:1874–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Habwe VQ. Posttransplantation quality of life: more than graft function. Am J Kidney Dis 2006; 47:S98–110.PubMedCrossRefGoogle Scholar
  12. 12.
    Rao VK. Posttransplant medical problems. Surg Clin N Am 1998; 78:113–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Euvrard S, Kanitakis J, Claudy A. Cutaneous complications after organ transplant. Presse Med 1999; 28:1833–838.PubMedGoogle Scholar
  14. 14.
    Snydman DR. Infection in solid organ transplantation. Transplant Infect Dis 1999; 1:21–28.CrossRefGoogle Scholar
  15. 15.
    Patel R, Paya CV. Infections in solid organ transplantation recipients. Clin Microbiol Rev 1997; 10:86–124.PubMedGoogle Scholar
  16. 16.
    Bromberg JS, Grossman RA. Care of the organ transplant recipient. J Am Board Fam Pract 1993; 6:563–76.PubMedGoogle Scholar
  17. 17.
    Villacian JS, Paya CV. Prevention of infections in solid organ transplant recipients. Transplant Infect Dis 1999; 1:50–64.CrossRefGoogle Scholar
  18. 18.
    Guggenheimer J, Eghtesad B. Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95:383–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001; 33:S26–31.PubMedCrossRefGoogle Scholar
  20. 20.
    Virgili A, Zampino MR, Mantovani L. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol 2002; 3:19–35.PubMedCrossRefGoogle Scholar
  21. 21.
    EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipients. 11. Paediatrics. Nephrol Dial Transplant 2002; 17S4:55–8.Google Scholar
  22. 22.
    Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7:147–56.PubMedGoogle Scholar
  23. 23.
    Chapman J, Webster A. Cancer report. Chapter 10. ANZDATA Registry 2004 Report, pp 100–103.Google Scholar
  24. 24.
    Lutz J, Heemann U. Tumours after kidney transplantation. Curr Opin Urol 2003; 13:105–09.PubMedCrossRefGoogle Scholar
  25. 25.
    Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transplant 1998; 12:147–94.Google Scholar
  26. 26.
  27. 27.
    Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905–13.PubMedCrossRefGoogle Scholar
  28. 28.
    Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant 2007; 22(Suppl 1):S4–10.CrossRefGoogle Scholar
  29. 29.
    Belloni Fortina A, Piaserico S, Caforio ALP, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140:1079–85.CrossRefGoogle Scholar
  30. 30.
    Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149:1221–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Lindelöf B, Dal H, Wolk K, Malmborg N. Cutaneous squamous cell carcinoma in organ transplant recipients. Arch Dermatol 2005; 141:447–51.PubMedCrossRefGoogle Scholar
  32. 32.
    Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146:1–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Staples MP, Elwood M, Burton RC, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184:6–10.PubMedGoogle Scholar
  34. 34.
    Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005; 26:1657–67.PubMedCrossRefGoogle Scholar
  35. 35.
    Ulrich C, Schmook T, Sachse MM, et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30:622–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Stasko T, Brown MD, Carucci JA, et al. International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30:642–50.PubMedCrossRefGoogle Scholar
  37. 37.
    Ismail F, Mitchell L, Casabonne D, et al. Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. Br J Dermatol 2006; 155:916–25.PubMedCrossRefGoogle Scholar
  38. 38.
    Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancer in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81:1093–100.PubMedCrossRefGoogle Scholar
  39. 39.
    Christenson LJ, Geusau A, Ferrandiz C, et al. Specialty clinic for the dermatologic care of solid-organ transplant recipients. Dermatol Surg 2004; 30:598–603.PubMedCrossRefGoogle Scholar
  40. 40.
    Otley CC. Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatol Surg 2000; 26:709–12.PubMedCrossRefGoogle Scholar
  41. 41.
    EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long term management of the transplant recipient. 10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002; 17:S50–5.Google Scholar
  42. 42.
    Galbraith CA, Hathaway D. Long-term effects of transplantation on quality of life. Transplantation 2004; 77:S84–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Stowe J, Kotz M. Addiction medicine in organ transplantation. Prog Transplant 2001; 11:50–57.PubMedGoogle Scholar
  44. 44.
    Roland ME, Stock PG. Solid organ transplantation is a reality for patients with HIV infection. Curr HIV/AIDS Rep 2006; 3:132–38.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Alexandra Geusau
    • 1
  • Erich Pohanka
    • 2
  1. 1.Division of Immunology, Department of Dermatology, Allergy and infectious DiseasesMedical University of ViennaViennaAustria
  2. 2.Division of Nephrology and DialysisInternal Medicine III, Medical University of ViennaViennaAustria

Personalised recommendations